CClinicalTrials.gg
RecruitingNCT07524907STRIKEUpdated Jul 24, 2026

Stunting and Targeting Reduction of Impaired Growth in Kids Effectively

An observational study in Malnutrition (Calorie), sponsored by Abbott Nutrition. Recruiting at 1 site in United States. Open to participants aged 1 Year to 5 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Abbott Nutrition · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
158
Ages
1 Year to 5 Years
Sex
All
01

Study summary

The objective of this prospective, real-world evidence/pragmatic study with a quality improvement program approach is to evaluate the feasibility and effectiveness of a community-engaged nutrition-focused program utilizing nutrition screening, education, supplementation and continuous follow up for children and their families.

02

Conditions studied

  • Malnutrition (Calorie)

Browse trials for

03

Who can participate

Ages eligible
1 Year to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Via screening by existing community-based programming via Children International (NGO)

Eligibility criteria

Household Component

Inclusion

  • Children aged 1-5 years experiencing stunting or its risk (defined as HAZ ≤ -1 SD at baseline)
  • Children's legal guardian agrees to participate in the study
  • Full term pregnancy (defined as ≥ 37 weeks gestation and ≥ 2500g birth weight)
  • Residence in study area attending Children International (NGO) centers

Exclusion

  • Children who have current medical conditions requiring hospitalization: gastrointestinal tract infections or inflammatory bowel disease; active tuberculosis; acute hepatitis B or C; human immunodeficiency virus OR malignancy; cystic fibrosis; immunodeficiency syndromes, congenital abnormalities of the respiratory tract, such as lung and respiratory cilia; an unsuspected foreign body in the respiratory tract; asthma; heart abnormalities; abdominal hernias; and known metabolic disorders, renal impairment, or rheumatic diseases and diabetes
  • Congenital condition
  • Children with disabilities such as cerebral palsy, autism spectrum disorder, neurodegenerative disorders
  • Children with chronic or acute infections e.g. HIV, malaria
  • Children who are taking medications or other agents that could potentially affect body weight, including diuretics, appetite stimulants, steroids, and growth hormones
  • Children who have genetic conditions impacting weight status such as but not limited to: Bardet-Biedl Syndrome, Prader-Willi Syndrome
  • Children already enrolled in a nutrition program that includes a supplement
  • Participant has an allergy or intolerance to any ingredient in the study supplement, as reported by the parent.
  • Children with sleep disorders such as but not limited to: obstructive sleep apnea, insomnia, parasomnias (sleepwalking, night terrors, bedwetting), delayed sleep phase syndrome, behavioral sleep disorders, circadian rhythm disorders
  • Mental health disorders such as but not limited to: anxiety, depression

Organization Component

Inclusion

  • NGO staff taking part in nutrition screenings
  • Agrees to participate in survey

Exclusion

  • Not involved in the implementation of the study
  • Not involved in working with pediatric stunting or its risk
  • Declines participation in survey
04

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
158 participants (estimated)
Patient registry
No

Groups and cohorts

  • Household

    Includes eligible Children and their Caregivers

  • Organization

    NGO Staff

05

What researchers measure

Primary outcomes

  1. Program Feasibility

    Caregiver and NGO staff program experience assessed via survey via Net Promoter Score (NPS) scored from 0 to 10 where higher score is more favorable

    Time frame: Baseline to 12 months

  2. Growth Anthropometrics

    Change in Height (cm), Head Circumference (cm), Weight (kg) and Mid-Upper Arm Circumference (MUAC) (mm) as compared to pediatric growth standards (i.e. percentiles and z-scores)

    Time frame: Baseline to 3, 6, 9, and 12 months

Secondary outcomes

  1. Healthcare Resource Utilization

    Caregiver completed open ended questions to obtain the frequency of healthcare resource utilization including illness frequency, severity and related missed school/work days, where more utilization means worse outcomes.

    Time frame: Baseline, 6 and 12 months

  2. Pediatric Quality of Life Inventory

    A 23-item questionnaire rated 0 to 4 where higher scores indicate better health-related quality of life

    Time frame: Baseline, 6, and 12 months

  3. World Health Organization Quality of Life Brief Version

    A 26-item caregiver completed questionnaire scored 0 to 100 where higher scores indicate higher quality of life

    Time frame: Baseline, 6, and 12 months

  4. Nutrient Intake

    Caregiver completed 24-hour dietary recall

    Time frame: Baseline, 3, 6, 9, and 12 months

  5. Pediatric Nutrition Risk Status via Anthropometrics

    Calculated from anthropometrics measurements as compared to established standards

    Time frame: Baseline, 3, 6, 9, and 12 months

Other outcomes

  1. Nutrition Behavior

    Parent completed 35-item questionnaire, where higher scores indicate higher levels for that specific eating behavior

    Time frame: Baseline, 6, and 12 months

  2. Staff Experience Survey

    Assesses caregiver experience, satisfaction, and recommendations for improvement regarding the nutrition program using a combination of closed- and open-ended questions. Closed-ended questions will use Likert-scale responses ranging from strongly disagree to strongly agree.

    Time frame: 12 Months

  3. Nutrition Program Enrollment and Adherence

    Enrollment and adherence to the nutrition program

    Time frame: 12 Months

  4. Caregiver Experience Survey

    Assesses caregiver experience, satisfaction, and recommendations for improvement regarding the nutrition program using a combination of closed- and open-ended questions in addition to the Net Promoter Score (NPS). Closed-ended questions will use Likert-scale responses ranging from strongly disagree to strongly agree or very unsatisfied to very satisfied.

    Time frame: 12 Months

06

Study locations

1 of 1 sites recruiting
  • Children International
    Kansas City, Missouri 64121, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07524907
Lead sponsor
Abbott Nutrition
Collaborators
Children International
Responsible party
Sponsor
First posted
Apr 13, 2026
Start date
May 11, 2026
Primary completion
Jan 2028 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jul 24, 2026

Study contacts

Christina Becherer Children International
Contact
cbecherer@children.org
207-592-4917
Amy Sharn, MS, RDN, LD
study chair · Abbott

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion